- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Various cancers
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Gemcitabine – March 2025
Gemcitabine; Solution for injection 1 g (as hydrochloride) in 25 mL, Solution for injection 2 g (as hydrochloride) in 50 mL; Gemcitabine Sandoz®
Last updated
12 March 2025